Gene Query: GOLGA4

Dataset Description Geneva Score
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 101.5
Altering cancer transcriptomes using epigenomic inhibitors 101.5
An RNA-centric dissection of host complexes controlling flavivirus infection 96.0
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 96.0
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 86.21
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 82.86
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 73.83
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 67.31
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 53.65
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 53.1
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 49.1
hTERT promotes cell adhesion and migration independent of telomerase activity 48.79
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 48.37
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 48.08
The contribution of Alu exons to the human proteome 47.77
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 45.45
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 42.89
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 39.34
Human cell line and subcutaneous tumor 37.32
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 34.86
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 34.0
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 32.35
Targeting EZH2 in MYCN-amplified Neuroblastoma 32.35
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 32.25
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 32.25
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 31.4
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 30.09
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 30.01
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 29.3
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 29.19
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 28.88
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 28.28
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 26.9
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 26.38
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 25.48
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 25.4
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 24.84
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 24.59
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 24.14
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 24.02
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 24.01
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 23.82
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 23.81
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 23.63
Active translatome profiling with RiboLace in MCF7 cells 23.61
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 23.59
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 23.29
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 23.2
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 23.01
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 23.01
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 22.98
Global expression profiles in cardiac progenitor cells generated by ISX-9 22.98
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 22.97
Genes significantly down or Up-regulated upon RNF219 knockdown 22.9
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 22.74
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 22.61
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 22.19
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 22.12
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 21.67
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 21.63
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 21.63
High-throughput sequencing of PROMPT-enriched samples. 21.45
Exogenous rescue of KLHL9 in SF210 cell line 21.43
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 21.29
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 21.28
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 21.28
Transcriptomic analysis of the HOTAIR-regulated genes 20.82
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 20.82
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 20.36
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 20.19
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 19.86
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 19.86
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 19.85
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 19.36
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 19.36
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 19.3
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 19.09
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 19.08
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 18.8
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 18.78
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 18.64
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 18.64
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 18.61
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 18.41
Profiling of escape kinetics of viruses subjected to RNAi 18.4
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 18.22
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 18.19
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 18.07
MYCi975 regulates MYC target genes 17.93
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 17.91
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 17.85
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 17.75
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 17.44
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 17.34
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 17.31
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 17.28
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 17.28
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 17.14
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 16.99
Gene expression analysis of immortalized human liver progenitor-like cells in culture 16.92
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 16.86
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 16.76
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 16.61
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 16.59
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 16.54
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 16.42
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 16.16
miR941 overexpression experiment 16.15
Glioblastoma stem cells infected by ZIKA virus 16.13
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 16.11
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 16.11
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 15.91
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 15.78
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 15.78
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 15.63
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 15.44
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 15.34
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 15.16
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 15.15
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 15.15
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 15.14
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.03
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 14.99
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 14.79
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 14.72
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 14.68
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 14.58
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 14.58
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 14.47
Human embryonic stem cells in E8 and AKIT culture medium 14.34
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 14.34
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 14.15
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 14.15
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 14.13
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 14.05
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 14.02
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 13.99
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.94
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 13.91
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.83
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 13.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 13.7
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 13.7
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.68
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.68
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.65
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.64
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 13.63
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 13.63
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 13.51
Generation and functional characterization of MDSC-like cells 13.3
Microprocessor mediates transcription termination in long noncoding microRNA genes 13.24
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 13.15
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 13.13
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 13.06
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 13.04
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 13.02
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 12.98
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 12.9
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.72
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 12.72
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 12.7
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.52
Knockdown of ADNP in HCT116 colon cancer cells 12.45
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 12.36
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 12.34
Recovery and analysis of nascent RNA 12.34
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 12.31
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 12.3
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 12.12
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  12.12
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 12.05
Differences in miRNA Detection Levels are Technology and Sequence Dependent 12.05
Unique features and clinical importance of acute alloreactive immune responses 11.95
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 11.92
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 11.92
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.9
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.81
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 11.78
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 11.78
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 11.76
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 11.73
3’ Uridylation Expands miRNA Target Repertoire 11.58
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.58
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.58
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 11.56
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 11.56
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 11.54
JunB control of keratinocyte-mediated inflammation [RNA-seq] 11.54
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.51
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 11.4
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 11.28
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 11.26
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 11.26
BASP1 modifies the Tamoxifen response 11.13
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 11.12
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 11.12
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.05
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 10.91
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 10.91
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 10.85
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 10.85
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 10.84
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.82
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 10.81
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 10.79
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 10.79
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 10.77
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 10.73
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.69
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 10.6
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 10.58
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.54
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.52
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.47
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 10.4
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 10.36
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.28
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 10.28
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 10.28
Capturing the Interactome of Newly Transcribed RNA (RICK) 10.28
Capturing the Interactome of Newly Transcribed RNA 10.28
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.26
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 10.22
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 10.18
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.15
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.15
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 10.13
RNA-sequencing in irradiated and normal A549 cells. 10.09
mRNA recovered upon RNF219 IP. [RNA-IP] 10.03
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 10.01
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 10.01
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 9.85
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 9.85
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 9.84
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 9.84
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.83
Exploring ILF2 regulatory genes by next-generation sequencing 9.82
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.8
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 9.75
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 9.71
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 9.7
The transcriptome effect of overexpressing EZH2 in MCF7 9.68
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 9.56
RNA-seq of tumor cells following angiopellosis extravasation 9.52
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 9.49
Enhancer activation during EGF response 9.46
Role for citron kinase in prostate cancer growth 9.44
The regulartory role of ZCCHC24 in splicing machinery 9.43
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 9.4
Effect of nuclear IL-33 on gene expression 9.39
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.23
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 9.22
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.21
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 9.17
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 9.05
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 9.05
Genome-wide discovery of human splicing branchpoints 9.03
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.0
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 8.92
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 8.92
K562 polyA RNA-Seq 8.9
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.83
Tracing Enhancer Networks using Epigenetic Traits (TENET) 8.8
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 8.77
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 8.77
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.74
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.72
Solid phase chemistry to covalently and reversibly capture thiolated RNA 8.71
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 8.68
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.67
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.63
Determination of tRNA aminoacylation levels by high throughput sequencing 8.61
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 8.55
Efficient and quantitative high-throughput tRNA sequencing 8.52
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 8.42
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 8.41
RNA sequencing of human mammary epithelial cells 8.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 8.28
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 8.28
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.27
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 8.25
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 8.23
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 8.19
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 8.19
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.15
RNA Seq of HMVEC under hypoxia 8.08
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.08
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.04
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.0
Transcription elongation regulates genome 3D structure 7.95
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 7.89
The cohesin release factor WAPL restricts chromatin loop extension. 7.87
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 7.87
RNA-Seq of PRMT1 overexpression ECA109 cells 7.83
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.78
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 7.6
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 7.58
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 7.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 7.55
X-Ray induced DNA-Hydroxymethylation changes 7.36
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 7.31
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 7.27
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.21
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 7.15
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.11
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 7.06
A role for ZNF598 in post-transcriptional gene regulation 6.92
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 6.77
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 6.77
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 6.75
CD73 knockdown effect in pancreatic cancer cell lines 6.75
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 6.74
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.72
Gene expression signatures of innate lymphoid cells from human blood 6.7
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.69
FOXD3 is a novel tumor suppressor in lung cancer 6.52
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 6.43
Copper Regulation of HIF-1 Transcription Activity 6.35
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 6.35
RNA-seq of shEZH2 cells 6.34
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 6.3
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.05
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.98
RNA-seq of RKO cells with cTAZ KO or putback 5.98
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.96
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 5.9
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 5.88
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.88
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.88
Endothelial gene expression analysis 5.86
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.86
A novel target of EZH1/2 for treatment of mantle cell lymphoma 5.81
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.76
Ro60-knockout cells 5.76
RNA-seq analysis of control and Myc-induced U2OS cells 5.72
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.72
Regulatory network controlling tumor-promoting inflammation in human cancers 5.72
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 5.67
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.57
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.56
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 5.54
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.51
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.38
Aneuploidy triggers an immune response 5.36
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 5.33
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.26
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 5.2
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.2
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 5.15
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 5.15
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 5.14
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.07
RNA Sequencing of Human iPS derived Cardiomyocytes 5.05
PTHrP overexpression in MCF7 cells 5.03
An siRNA screen identifies CHD4 as a target for epigenetic therapy 5.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.88
RNA-Sequencing of HepG2 cells treated with TGFBeta 4.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.87
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.85
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.84
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.84
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.81
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 4.77
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 4.73
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 4.68
Gene expression analysis of human hepatocellular cancers 4.63
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.58
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.56
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 4.54
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.46
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.4
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.36
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.36
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.27
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 4.2
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 4.15
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 4.11
Effects of transcription on genome - nuclear lamina interactions 4.11
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.08
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 4.0
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.99
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.94
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.64
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.63
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.62
CDK12 mediated transcriptional regulation in U2OS cells 3.59
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 3.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.44
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.44
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 3.36
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.32
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.31
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.3
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.3
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 3.28
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 3.27
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.23
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.23
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 3.22
Identification of renal resident macrophages across species [C1] 3.22
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.2
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 3.18
Measure transcript integrity using RNA-seq data 3.17
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.09
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.02
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.86
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.84
Identification of renal resident macrophages across species 2.75
RNA seq comparison between scrambled and shGRP78 cells 2.71
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.71
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.68
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.62
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.5
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 2.49
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.48
Metastasis in triple-negative breast cancer 2.48
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.46
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.4
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.36
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.32
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.26
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.26
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.17
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.17
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.08
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.08
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.04
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.03
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.01
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.01
EGR1-controlled transcriptome of T HESCs 1.96
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.95
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.86
RNAseq of cell lines with knocked in ESR1 mutations 1.8
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.74
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.7
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 1.69
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.67
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.66
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.65
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.64
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.61
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.55
Human Treg IL-12 stimulation 1.4
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.39
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.36
Postnatal lipids drive hepatocyte maturation 1.35
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.34
UV_24h_GRO-Seq 1.25
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.23
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.21
Noncoding regions are the main source of targetable tumor-specific antigens 1.17
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.12
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.07
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.07
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.05
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.04
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.96
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.94
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.94
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.9
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.86
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.84
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.79
MicroRNA-125a-5p overexpression in human macrophages 0.77
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.73
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.73
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.71
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.66
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.59
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.58
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.58
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.58
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.56
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.55
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.54
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.5
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.45
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.45
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.41
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.38
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.37
A code of mono-phosphorylation modulates the function of RB. 0.32
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.27
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.26
The role of the Calcium-Sensing receptor in colorectal cancer 0.24
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.23
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.23
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.22
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.2
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.18
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.14
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.12
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.1
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation